ADC Therapeutics is a commercial-stage biotechnology company improving the lives of those affected by cancer with our next-generation, targeted antibody drug conjugates (ADCs). With an ADC platform validated by the FDA approval of ZYNLONTA® and a deep understanding of the oncology treatment landscape, we are working to address significant unmet medical needs and improve outcomes for those with difficult-to-treat hematological cancers and solid tumors. Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in London (R&D), New Jersey (Clinical and Commercial), and the San Francisco Bay Area (CMC). Our highly skilled global team is committed to confronting cancer with the full potential of our science, bringing unique, targeted therapies and hope to patients and their families. For more information, please visit https://www.adctherapeutics.com/ and follow us on Twitter @adctherapeutics.
View Top Employees from ADC TherapeuticsWebsite | http://www.adctherapeutics.com |
Ticker | ADCT |
Revenue | $80.4 million |
Funding | $1.1 billion |
Employees | 340 (340 on RocketReach) |
Founded | 2011 |
Address | Biopole 3b Rte De La Corniche, Epalinges, Vaud 1066, CH |
Phone | +41 21 653 02 00 |
Technologies |
JavaScript,
HTML,
PHP
+55 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Manufacturing General, Manufacturing, Science and Engineering, Drug Discovery, Medical, Health Care |
Web Rank | 3 Million |
Keywords | Cancer Research, Targeted Cancer Therapies, Solid Tumors, Molecular Oncology, Biopharmaceuticals, Healthcare Innovation, Clinical Trials, Biotechnology |
Competitors | G1 Therapeutics, Inc., Mersana Therapeutics, Mirati Therapeutics Inc, Pascal Biosciences Inc., Turning Point Therapeutics |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541712 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies |
Looking for a particular ADC Therapeutics employee's phone or email?
The ADC Therapeutics annual revenue was $80.4 million in 2024.
340 people are employed at ADC Therapeutics.
ADC Therapeutics is based in Epalinges, Vaud.
The NAICS codes for ADC Therapeutics are [54171, 54, 541712, 541, 541711, 5417].
The SIC codes for ADC Therapeutics are [28, 283].